Market Access/ News/ News Gilead files first hepatitis delta therapy with FDA Phil Taylor bulevirtide, Eiger Biopharmaceuticals, Gilead Sciences, hepatitis D, Hepcludex, lonafarnib, Zokinvy 0 Comment Gilead Sciences has submitted its marketing application for bulevirtide, its antiviral therapy for rare hepatitis delta virus (HDV) Share X Gilead files first hepatitis delta therapy with FDA https://pharmaphorum.com/news/gilead-files-first-hepatitis-delta-therapy-with-fda/